Literature DB >> 15296038

Pediatric cancer research from past successes through collaboration to future transdisciplinary research.

Gregory H Reaman1.   

Abstract

Multidisciplinary collaboration in therapeutic research in childhood cancer has been responsible for enormous improvements in outcomes. Many of the improvements have resulted from large clinical trials carried out in multisite settings through the Children's Oncology Group (COG) and its predecessors, the Children's Cancer Group, the Pediatric Oncology Group, the National Wilms' Tumor Study, and Intergroup Rhabdomyosarcoma Study Groups. Childhood acute lymphoblastic leukemia models the past success of 35 years of randomized clinical trials that resulted in survival rates of around 80%. However more can be done to improve both survival rates and the quality of survival. Areas that can benefit from a transdisciplinary model of research are discussed, as well as challenges to this form of collaboration.

Entities:  

Mesh:

Year:  2004        PMID: 15296038     DOI: 10.1177/1043454204264406

Source DB:  PubMed          Journal:  J Pediatr Oncol Nurs        ISSN: 1043-4542            Impact factor:   1.636


  12 in total

1.  National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing.

Authors:  Min H Kang; Malcolm A Smith; Christopher L Morton; Nino Keshelava; Peter J Houghton; C Patrick Reynolds
Journal:  Pediatr Blood Cancer       Date:  2010-10-04       Impact factor: 3.167

2.  The Role of Precision Medicine in Child Psychiatry: What Can We Expect and When?

Authors:  Jonathan Posner
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-11       Impact factor: 8.829

3.  The crucial role of tumour specimen handling in childhood cancer outcomes.

Authors:  Conrad V Fernandez; Fergall Magee; Robert B Fraser
Journal:  Paediatr Child Health       Date:  2005-10       Impact factor: 2.253

4.  CD22ΔE12 as a molecular target for RNAi therapy.

Authors:  Fatih M Uckun; Hong Ma; Jianjun Cheng; Dorothea E Myers; Sanjive Qazi
Journal:  Br J Haematol       Date:  2015-02-06       Impact factor: 6.998

Review 5.  Diet and exercise interventions for pediatric cancer patients during therapy: tipping the scales for better outcomes.

Authors:  Keri L Schadler; Eugenie S Kleinerman; Joya Chandra
Journal:  Pediatr Res       Date:  2017-10-25       Impact factor: 3.756

6.  Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999.

Authors:  Amy M Linabery; Julie A Ross
Journal:  Cancer       Date:  2008-11-01       Impact factor: 6.860

Review 7.  Spinal muscular atrophy.

Authors:  Maryam Oskoui; Petra Kaufmann
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

8.  A social network analysis of treatment discoveries in cancer.

Authors:  Athanasios Tsalatsanis; Laura Barnes; Iztok Hozo; John Skvoretz; Benjamin Djulbegovic
Journal:  PLoS One       Date:  2011-03-28       Impact factor: 3.240

9.  Multidisciplinary care in pediatric oncology.

Authors:  Mary Ann Cantrell; Kathy Ruble
Journal:  J Multidiscip Healthc       Date:  2011-05-30

10.  Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: the university of Texas MD anderson cancer center experience.

Authors:  Eugenie S Kleinerman; Razelle Kurzrock; Vivek Subbiah; Fernando F Corrales-Medina; Cynthia Herzog; Kenneth Hess; Daniela Egas-Bejar; David S Hong; Gerald Falchook; Pete Anderson; Cesar Nunez; Winston W Huh; Aung Naing; Apostolia M Tsimberidou; Jennifer Wheler; Sarina Piha Paul; Filip Janku
Journal:  Oncoscience       Date:  2014-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.